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Abstract  The aim of this study was to evaluate the role of Humphrey Matrix perimetry to better guide appropriate re-
ferral of at-risk individuals for glaucoma assessment. Fifty-two consecutive patients referred to a specialist glaucoma oph-
thalmology practice for an opinion about a new diagnosis of glaucoma were enrolled. Prior to assessment for presence of 
open-angle glaucoma, patients performed Humphrey Matrix perimetry with results withheld from both patient and assess-
ing glaucoma specialist. Humphrey Matrix perimetry results were later compared with the outcome of clinical assessment 
for each individual. Eleven of 52 participants were diagnosed with open-angle glaucoma (21.2%). Negative predictive 
value of Humphrey Matrix perimetry in this population ranged from 87.1% to 93.6% depending on the indices used. Only 
two individuals with normal Humphrey Matrix perimetry were diagnosed with open-angle glaucoma. These results suggest 
Humphrey Matrix perimetry displays a high negative predictive value when screening for open-angle glaucoma in an 
at-risk population. It may be useful in this context to better guide eye health professionals on appropriate referral of patients 
for an opinion about glaucoma. 
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1. Introduction 
Glaucoma is an important cause of visual impairment with 
an overall prevalence of 2%[1,2]. In most developed nations, 
half the glaucoma in the community remains undiagnosed[1]. 
As glaucoma is a progressive disorder that may cause 
blindness or significant visual field loss, earlier recognition 
and intervention are important.  
Examination by an eye health care professional for rea-
sons other than glaucoma provides an opportunity to detect 
and appropriately refer individuals with undiagnosed glau-
coma. However, eye health care professionals may not ac-
curately detect such cases and may miss the diagnosis in a 
significant number of individuals[3].  
In addition to risk factor assessment and optic disc ex-
amination, perimetry may have a useful role in screening for 
undiagnosed glaucoma. Problems with the use of perimetry 
for screening include expense of equipment, long test times 
and high false positive rates amongst naive subjects[4].  
Mitchell et al.,[1] reported false positive rates of 20% with-
supra-threshold perimetry, which would overwhelm our 
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ophthalmic services if such screening yielded referrals. 
While supra-threshold perimetry in a reduced number of 
stimulus locations may reduce the false positive rate, it does 
so at the cost of sensitivity[1,5].  
Frequency-doubling threshold (FDT) perimetry was de-
veloped in the hope of better detecting early glaucomatous 
visual field loss and may be suitable for this purpose. It uses 
a stimulus that non-linearly stimulates magnocellular retinal 
ganglion cells[6]. Perhaps because of reduced redundancy, 
damage to these cells can be detected relatively early in 
glaucoma[7-9]. FDT perimetry is comparable with achro-
matic perimetry for detecting established mild, moderate and 
severe field loss in glaucoma[10,11] and it identifies sig-
nificantly more patients with ocular hypertension that pro-
gress to glaucoma than does conventional achromatic pe-
rimetry[12,13]. 
A newer version of the FDT perimeter is the Humphrey 
‘Matrix’, which uses a 5-degree rather than 10-degree square 
stimulus. For the cental 24 degrees of field, the Humphrey 
Matrix tests 55 zones verses 17 in the original machine. This 
may yield improved performance. 
Given the known high false positive rates for perimetric 
screening, we wished to evaluate the ability of Matrix pe-
rimetry, performed after normal optometric assessment, to 
identify patients without glaucoma, thereby reducing the 
false positive rate of optometric referral for glaucoma. Thus 
2  Colin I Clement et al.:  Humphrey Matrix Perimetry for Open-Angle Glaucoma Screening in A High-Risk Population 
 
 
the aim of this study was to assess the predictive value (in 
particular, the negative predictive value) of Humphrey Ma-
trix perimetry in patients with a provisional diagnosis of 
open-angle glaucoma.  
2. Methods 
2.1 Subject Selection 
Subjects were recruited from an urban ophthalmology 
practice. The Human Research Ethics Committee of the 
South Eastern Sydney Area Health Service approved the 
study protocol. Informed consent was obtained from each 
participant. 
Patients newly referred to the practice for a specialist 
glaucoma assessment were eligible for enrolment in the 
study. Testing was performed on all suitable individuals 
irrespective of best-corrected visual acuity or the presence of 
non-glaucomatous ocular pathology. Patients were excluded 
if they had previously been diagnosed with glaucoma, had 
used anti-glaucoma medication(s) or had been referred be-
cause of a suspected angle closure mechanism. 
2.2 Assessment 
One of three ophthalmologists (IG, SLG or PRH) assessed 
all patients. A diagnosis was made on the basis of typical 
optic disc changes and / or the presence of glaucomatous 
visual field loss using SITA standard 24-2 automated pe-
rimetry (Humphrey Field Analyzer, Zeiss/Humphrey sys-
tems, Dublin, California, USA) according to previously 
described criteria[14]. Diagnosis was aided in all cases by 
the use of Goldmann applanation tonometry, ultrasonic 
pachymetry, gonioscopy, Heidelberg retinal optic disc to-
mography and optic disc photography. Patients diagnosed as 
‘glaucoma suspects’ after assessment were considered not to 
have glaucoma for the purpose of the analysis. 
2.3 Humphrey Matrix Perimetry 
We wished to simulate Matrix perimetry being performed 
after the optometrists had made a provisional diagnosis of 
glaucoma, but prior to ophthalmologist evaluation. In order 
to standardise data collection and masking, Matrix perimetry 
was performed at the ophthalmology practice, after visual 
acuity measurement but prior to any other test or assessment 
by the ophthalmologist. Each subject performed Humphrey 
Matrix perimetry (Humphrey Matrix, Zeiss/Humphrey sys-
tems, Dublin, California, USA and Welch Allen, Skaneateles 
Falls, New York, USA) using the 24-2 threshold algorithm 
that tests 55 zones in the central 24 degrees of vision. Each 
subject was instructed on the use of the Humphrey Matrix, 
shown the frequency doubling illusion on a card and then 
shown the fixation target and stimulus in simulation mode. 
Testing was performed in a dimly lit room and subjects wore 
their prescription glasses or contact lenses when correction 
was required. One of the authors (Dr CI Clement) supervised 
all Matrix perimetry. If fixation losses, false-positive or 
false-negative errors exceeded 33%, testing was stopped, the 
subject re-instructed and Matrix perimetry restarted. Patients 
who were not able to perform perimetry reliably despite the 
above measures were not included in the study. Both eyes 
were tested with the right eye always tested first. Results of 
the Matrix perimetry were withheld from both the patient 
and the assessing ophthalmologist. 
Both SITA 24-2 and Matrix 24-2 threshold tests were 
performed once for each patient and results used for data 
analysis. 
In order to reflect the screening use by 
non-ophthalmologists, Matrix tests were interpreted with the 
assistance of automated indices and did not require recogni-
tion of characteristic patterns of visual field loss. A Matrix 
field test was considered positive for glaucoma if either 
mean deviation (MD) or pattern standard deviation (PSD) 
had a p value < 5%, or if the glaucoma hemifield test (GHT) 
was abnormal. 
2.4 Statistical Analysis 
The GHT, MD with p < 5% and PSD with p < 5% as 
generated by the Humphrey Matrix were independently 
assessed as markers of an abnormal visual field. Sensitivity, 
specificity, positive-predictive value (PPV) and nega-
tive-predictive value (NPV) were calculated for GHT, MD, 
PSD and MD and PSD. 




Humphrey Matrix Automated Indices 
FDT GHT FDT MD P < 5% 
FDT PSD P 
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Bold italics: patients with normal Humphrey Matrix perimetry diagnosed 
with open-angle glaucoma 
3. Results 
Fifty-two consecutive newly referred patients were en-
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rolled in the study. The mean age was 53.58 ± 14.02 years 
(range, 18 – 81) with 61.5% females. Visual acuity was 1.01 
± 0.25 OD and 0.98 ± 0.29 OS. The commonest stated rea-
sons for provisional glaucoma diagnosis were “suspicious” 
optic disc morphology (24/52; 46.2%), positive family his-
tory (22/52; 42.3%), and/or raised intra-ocular pressure 
(22/52; 42.3%). Twenty-two participants (42.3%) had more 
than one risk factor. All but 2 patients had been referred 
directly from an optometrist. 
The average time taken to complete the Humphrey Matrix 
perimetry was 311.2 ± 13.2 seconds (range: 287 – 353 sec-
onds) for each eye. This was statistically, but not clinically, 
significantly faster than Humphrey SITA-standard 24-2 
perimetry which took 336.5 ± 67.8 seconds (range: 226 – 585 
seconds) (t-test; p = 0.0001). 
Following ophthalmological assessment, 11 of the 52 
participants were diagnosed with open-angle glaucoma 
(Table 1), a pre-test probability of 21.2%. 
Table 2 shows the diagnostic indices of Matrix perimetry. 
Using the GHT to indicate a positive result, sensitivity and 
specificity were calculated to be 63.6% and 65% respec-
tively, with a positive predictive value (PPV) 33.3%. Using 
MD as an indicator of a positive result, sensitivity fell 
slightly to 54.5% but specificity improved to 82.5%: PPV 
increased to 46.2%. Sensitivity was further improved to 72.7% 
when PSD was used. There was however a corresponding 
fall in specificity to 67.5% when compared with MD, how-
ever this was still better than GHT. PPV also fell to 38.1%. 
When either MD or PSD was considered to indicate a posi-
tive result, there was no benefit demonstrated compared with 
using PSD alone. 
Table 2.  Performance of Humphrey Matrix for Detecting the Presence of 
Open-Angle Glaucoma. 
 GHT MD PSD MD/PSD 
Sensitivity (%) 63.6 54.5 72.7 72.7 
Specificity (%) 65.9 82.9 68.3 68.3 
Positive Predictive 
Value (%) 33.3 46.2 38.1 38.1 
Negative Predictive 
Value (%) 87.1 87.2 90.3 90.3 
In contrast to PPV, the negative predictive value of Matrix 
perimetry was quite reasonable. Both GHT and MD gave 
similar values (87.1% and 87.2% respectively). When PSD 
was used, the negative predictive value rose to 90.3%. 
Negative predictive value was maximum (93.5%) when the 
three indices were considered simultaneously. 
4. Discussion 
Despite the need, attempts to develop a screening test for 
glaucoma have not been successful to date. Traditionally 
tonometry has been the most popular means of screening for 
glaucoma, but sensitivity and specificity are too poor to be of 
any practical use alone[15]. Optic nerve head examination 
requires an experienced examiner and standard automated 
perimetry (SAP) remains expensive, poorly portable, with 
long testing times and displays a learning curve often ren-
dering the first test unhelpful[4]. Further, findings from 
anatomical work suggest up to 50% of RGCs are lost before 
field defects are detected on SAP[16] making it unsuitable 
for detecting early disease.  
This study differs from previous reports on perimetric 
screening for open-angle glaucoma in two principal ways: (i) 
the performance of Humphrey Matrix frequency doubling 
perimetry was evaluated; and (ii) perimetry was performed 
after a screening diagnosis of glaucoma was made and con-
founders of field abnormality or other eye diseases requiring 
referral (such as cataract) had been excluded. This repre-
sented a population at the highest identified glaucoma risk in 
the current health system. As such, the principle aim of the 
study was to determine whether Matrix perimetry could 
assist in the appropriate referral of patients with open-angle 
glaucoma. In this context, the main outcome of interest was 
negative predictive value of the Matrix for screening. This 
value determines the confidence with which one can exclude 
open-angle glaucoma based on the Matrix result.  
The negative predictive value of Matrix perimetry was 
good, ranging from 87.1% to 90.3% when GHT, MD or PSD 
were used as a measure of an abnormal result (Table 2). 
When the three indices were considered simultaneously, 
negative predictive value improved to 93.5%; that is of the 
31 individuals with a normal Humphrey Matrix perimetry 
result, only 2 (6.5%) actually had glaucoma. The other 29 
individuals without glaucoma in whom perimetry was nor-
mal could have avoided referral assessment had the Hum-
phrey Matrix been used to guide referral. That 6.5% of in-
dividuals with glaucoma were missed initially appears to be 
a bad outcome. However, such patients are likely to have an 
ongoing relationship with their eye health professional and 
would have opportunities for repeat testing. The total num-
ber of patients missed over time may therefore be less than 
we report here. 
These findings are consistent with the notion that FDT 
perimeters are better able to detect early RGC loss compared 
with SAP[6]. A negative result in such a perimeter is more 
likely to result from absent RGC damage, hence the high 
negative predictive value. Of the two glaucoma cases with a 
normal Humphrey Matrix result, both were male. One was 
referred because of raised IOP alone and the other a com-
bination of raised IOP and suspicious optic disc morphology 
Both had prior perimetric experience and performed both 
SAP and Humphrey Matrix perimetry reliably on the day of 
testing. There were no obvious indications as to why in both 
cases Humphrey Matrix perimetry was normal despite 
structural evidence of open-angle glaucoma.  
Using automated indices for Matrix assessment raises the 
possibility of some individuals performing at a su-
pra-physiological level (compared to the normative data-
base), giving good test sensitivities despite early structural 
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damage. Even in such individuals, one would expect the PSD 
to highlight differences between areas of damage and 
non-damage. Another possibility is that the temporal pattern 
of RGC loss may not be the same in each case. Although 
there is strong support for preferential magnocellular RGC 
loss early in the pathogenesis of glaucoma[7], there is evi-
dence also supporting preferential targeting of koniocellular 
RGCs[17]. Matrix perimetry would not be expected to detect 
glaucomatous visual field loss in these individuals because 
of the response properties of koniocellular RGCs. Alterna-
tively, in individuals with preferential parvocellular RGC 
damage[18], early cell loss may not be detected by Matrix 
perimetry because of increased redundancy within this visual 
system as well as response properties.  
The sensitivity, specificity and positive predictive values 
for Matrix perimetry in this population are noteworthy be-
cause FDT perimetry has been theorised to be better adapted 
for screening on a population basis[6]. Some studies of 
glaucoma screening suggest FDT perimetry is a promising 
technique for early detection[9,19] but others argue im-
proved specificity and positive predictive value are required 
for it to be useful[20]. We found Humphrey Matrix pe-
rimetry accurate for excluding early glaucoma in up to 93.5% 
of at-risk patients without the disease. This represents a 
significant improvement in specificity over the original FDT 
perimeter[20]. Improved specificity may be the result of 
reduced target size, which theoretically facilitates detection 
of smaller, earlier visual field defects. We found the positive 
predictive value of the Humphrey Matrix to be in the range 
of 33 – 46%. This represents a doubling of positive predic-
tive value compared with referral of high-risk individuals 
without the test . However, if one assumes a general popu-
lation prevalence of 2% for glaucoma[1,2] then PPV for 
Humphrey Matrix would be approximately 4%. This is no 
different from rates reported for conventional FDT pe-
rimetry[20]. Although the main influence on positive pre-
dictive value is disease prevalence, other reasons for such a 
low value might include patient factors such as the effects of 
intercurrent ocular pathology, refractive error, test inexpe-
rience or fatigue. 
We attempted to assess the influence of other factors by 
analysing the impact of excluding patients that had other 
ocular pathology or refractive error outside the usual ± 
6-dioptre reference range. Although 5/52 patients had other 
ocular pathology and 2/52 patients had > 6-dioptres of re-
fractive error, their exclusion resulted in little improvement 
in PPV. This leaves test inexperience and fatigue as potential 
sources of error. Test-retest variability[21,22] and learning 
effect[23] have already been shown to significantly influence 
SAP results and the same appears to be true for Humphrey 
Matrix perimetry. Several studies indicate Humphrey Matrix 
perimetry indices, most notably mean deviation, improve 
with repeat testing in individuals with or without glau-
coma[24–26]. One study[24] has indicated the learning ef-
fect is largely gone by the second test whilst in others it 
persists beyond the third[25,26]. Regardless, the overall 
influence of learning may be less than described for 
SAP[27,28]. The importance of this in perimeters using FDT 
is reinforced by the finding that repeat testing during glau-
coma screening improves test sensitivity and specific-
ity[20,29].  
That test inexperience may be an influential factor in both 
SAP and Matrix perimetry highlights a potential source of 
bias in this study. Many of the participants had not per-
formed SAP prior to enrolment and none had performed 
Matrix perimetry, potentially exposing them to factors out-
lined above. It is possible that some patients initially diag-
nosed with glaucoma, had a false positive SAP. However, a 
diagnosis of glaucoma was never made solely on the basis of 
SAP results, but in conjunction with corroborating optic disc 
and nerve fibre layer pathology. 
Performance of SAP followed by Matrix perimetry in the 
same sitting is another potential source of bias. Second tested 
eyes with FDT perimetry display a fatigue effect[30] and this 
may also be the case for Humphrey Matrix perimetry. One 
might expect that testing with SAP immediately prior to 
Humphrey Matrix could exaggerate this effect although we 
are not aware of any work that has specifically addressed this 
issue. Strategies for future studies and clinical applications 
of Humphrey Matrix perimetry might include testing on 
different days, retesting to confirm perimetry results or using 
different testing algorithms[20,29,31]. 
5. Conclusions 
In conclusion, Humphrey Matrix perimetry may be useful 
to guide eye health professionals about referral of patients 
for a glaucoma opinion in situations of uncertainty. 
Two-thirds of patients with risk factors for the condition but 
in whom glaucoma is not present may avoid unnecessary 
referral when Humphrey Matrix perimetry is used and found 
to be normal. 
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